A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

August 12, 2018 updated by: Intec Pharma Ltd.

An Open-Label,Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of AP-CD/LD in Fluctuating Parkinson's Disease Subjects Who Completed Study IN 11 004

The purpose of this study is to allow evaluation of long-term clinical effect and safety outcome of treatment with AP-CD/LD, as well as to allow patients to benefit from extended treatment duration with AP-CD/LD after they have successfully completed the Phase 3 core study IN 11 004 ('core study', a phase III, multicenter, randomized, double-blind, double-dummy, active-controlled Phase 3 study to assess the safety and efficacy of AP CD/LD versus IR CD/LD in fluctuating PD patients).

Study Overview

Status

Unknown

Conditions

Detailed Description

This will be a multi-center, global, open-label study in adult suffering from fluctuating Parkinson's disease subjects who have successfully completed the core study IN 11 004.

After signing informed consent and meeting inclusion/exclusion criteria, eligible subjects will be enrolled into a 12-month open-label extension and receive the AP-CD/LD as needed.

Efficacy and safety will be assessed throughout the study period.

Study Type

Interventional

Enrollment (Anticipated)

460

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pleven, Bulgaria, 5800
        • Not yet recruiting
        • MHAT 'Sv.Pantaleymon - Pleven' OOD
        • Contact:
      • Sofia, Bulgaria, 1407
        • Not yet recruiting
        • Clinic for Neurology and Sleep Medicine
        • Contact:
      • Sofia, Bulgaria, 1797
        • Not yet recruiting
        • Clinic of Neurological Diseases
        • Contact:
          • Rosen Ikonomov, MD
          • Phone Number: +359888766461
          • Email: drros@abv.bg
      • Aschaffenburg, Germany, 63755
        • Not yet recruiting
        • Neuroakademie Alzenau GbR
        • Contact:
      • Dresden, Germany, 01307
      • Munchen, Germany, 81675
        • Not yet recruiting
        • Technischen Universitaet Muenchen (TUM) - Klinikum Rechts der Isar
        • Contact:
      • Haifa, Israel
      • Haifa, Israel
        • Recruiting
        • Rambam Health Care Campus, Haifa, Movement Disorders and Parkinson's Disease
        • Contact:
        • Principal Investigator:
          • Ilana Schlesinger, M.D
      • Petah Tiqva, Israel, 4941492
        • Recruiting
        • Rabin Medical Center
        • Contact:
      • Ramat Gan, Israel
      • Tel Aviv, Israel, 64239
        • Recruiting
        • Tel Aviv Sourasky Medical Center
        • Contact:
      • Tel Aviv, Israel
        • Recruiting
        • TASMC
        • Contact:
          • Y. Knaani
          • Phone Number: 972-3-6973061
        • Principal Investigator:
          • T. Gurevich, MD
      • Acquaviva delle Fonti, Italy, 70021
        • Not yet recruiting
        • Ospedale Generale Regionale Francesco Miulli
        • Contact:
      • Ancona, Italy, 60126
        • Not yet recruiting
        • Ospedali Riuniti Di Ancona
        • Contact:
      • Arcugnano, Italy, 36057
      • Brescia, Italy, 25123
        • Not yet recruiting
        • Spedali Civili Di Brescia Azienda Ospedaliera
        • Contact:
      • Napoli, Italy, 80131
        • Not yet recruiting
        • Azienda Ospedaliera Universitaria Federico II
        • Contact:
      • Pisa, Italy, 56126
        • Not yet recruiting
        • Azienda Ospedaliero-Universitaria Pisana
        • Contact:
      • Roma, Italy, 00168
        • Not yet recruiting
        • Fondazione Policlinico Universitario Agostino Gemelli
        • Contact:
      • Roma, Italy, 00163
      • Roma, Italy, 00178
        • Not yet recruiting
        • NCL Neurological Centre of Latium
        • Contact:
      • Salerno, Italy, 84131
        • Not yet recruiting
        • Azienda Ospedaliera Universitaria San Giovanni di Dio Ruggi d'Aragona
        • Contact:
        • Contact:
      • Varese, Italy, 21100
      • Czestochowa, Poland, 42-280
        • Not yet recruiting
        • Anna Kapustecka Prywatna Przychodnia Specjalistyczna STOMED
        • Contact:
      • Katowice, Poland, 40-749
        • Not yet recruiting
        • NEURO-CARE Site Management Organization Gabriela Klodowska-Duda
        • Contact:
      • Katowice, Poland, 40-954
        • Not yet recruiting
        • Centrum Medyczne Pratia Katowice I
        • Contact:
      • Krakow, Poland, 31-505
        • Not yet recruiting
        • Krakowska Akademia Neurologii Sp. z o. o.
        • Contact:
      • Lodz, Poland, 90-130
        • Not yet recruiting
        • Gabinet Lekarski Prof. Andrzej Bogucki
        • Contact:
      • Warszawa, Poland, 01-868
        • Not yet recruiting
        • Centrum Medyczne Pratia Warszawa
        • Contact:
      • Warszawa, Poland, 02-777
        • Recruiting
        • Centrum Medyczne Damiana Holding
        • Contact:
    • Trencin
      • Dubnica nad Váhom, Trencin, Slovakia, 01841
      • Barcelona, Spain, 08035
        • Not yet recruiting
        • Hospital Universitari Vall d'Hebron
        • Contact:
      • Madrid, Spain, 28006
        • Not yet recruiting
        • Hospital Universitario La Princesa
        • Contact:
      • Majadahonda, Spain, 28222
        • Not yet recruiting
        • Hospital Puerta de Hierro Majadahonda
        • Contact:
      • Manresa, Spain, 08243
        • Not yet recruiting
        • Hospital Sant Joan de Déu de Manresa
        • Contact:
      • Cherkasy, Ukraine, 18009
        • Not yet recruiting
        • Ukrainian State Scientific Research Institution of Medical and Social Problems of Disability
        • Contact:
      • Dnipropetrovs'k, Ukraine
        • Not yet recruiting
        • Dnipropetrovsk medical academy MOH of Ukraine
        • Contact:
      • Kharkiv, Ukraine, 61068
        • Not yet recruiting
        • Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine
        • Contact:
      • Kharkiv, Ukraine, 61068
        • Not yet recruiting
        • Kharkiv regional clinical psychiatry hospital #3
        • Contact:
      • L'viv, Ukraine, 79010
        • Not yet recruiting
        • Lviv City Clinical Hospital
        • Contact:
      • Poltava, Ukraine, 36024
        • Not yet recruiting
        • Regional Clinical Hospital n.a. N.V. Sklifosovskyi
        • Contact:
      • Vinnytsya, Ukraine, 21005
        • Not yet recruiting
        • Municipal Institution Vinnytsia Regional Psychoneurological Hospital n. a. Acad. O.I. Yushchenko
        • Contact:
      • Zaporozh'ye, Ukraine, 69600
        • Not yet recruiting
        • Clinical Hospital #2
        • Contact:
      • Zaporozh'ye, Ukraine, 69600
        • Not yet recruiting
        • Municipal Institution Zaporizhzhia Regional Clinical Hospital of Zaporizhzhia Regional Council
        • Contact:
      • Bury, United Kingdom, BL9 7TD
        • Not yet recruiting
        • Fairfield General Hospital
        • Contact:
      • Newcastle upon Tyne, United Kingdom, NE4 5PL
        • Not yet recruiting
        • Newcastle University Clinical Ageing Research
        • Contact:
      • Nottingham, United Kingdom, NG7 2UH
        • Not yet recruiting
        • Queens Medical Centre Nottingham, University Hospital
        • Contact:
      • Stoke-on-Trent, United Kingdom, ST4 6QG
        • Not yet recruiting
        • University Hospitals of North Midlands NHS Trust
        • Contact:
    • Alabama
      • Birmingham, Alabama, United States, 35233
        • Recruiting
        • University Alabama Hospital Neurology
        • Contact:
    • Arizona
      • Phoenix, Arizona, United States, 85013
        • Not yet recruiting
        • Saint Joseph's Hospital and Medical Center Muhammad Ali Parkinson Research Center
        • Contact:
      • Sun City, Arizona, United States, 85351
        • Terminated
        • Banner Sun Health Research Institute
    • California
      • Fountain Valley, California, United States, 92708
        • Not yet recruiting
        • Parkinson's Disease & Movement Disorders Center
        • Contact:
      • Loma Linda, California, United States, 92354
        • Not yet recruiting
        • Loma Linda University Medical Center
        • Contact:
      • Los Angeles, California, United States, 90033
        • Not yet recruiting
        • University of Southern California
        • Contact:
      • Pasadena, California, United States, 91105
      • Reseda, California, United States, 91335
    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • University of Colorado Dept. of Neurology
        • Contact:
    • Connecticut
    • Florida
      • Boca Raton, Florida, United States, 33486
        • Recruiting
        • Parkinson's Disease and Movement Disorders Center of Boca Raton
        • Contact:
      • Naples, Florida, United States, 34102
      • Orlando, Florida, United States, 32806
      • Tampa, Florida, United States, 33613
        • Recruiting
        • Parkinson's Disease and Movement Disorders Center
        • Contact:
          • Leigh Harrell
          • Phone Number: 813-396-0768
    • Illinois
      • Chicago, Illinois, United States, 60612
        • Recruiting
        • Rush University Medical Center
        • Contact:
    • Kansas
      • Kansas City, Kansas, United States, 66160
        • Recruiting
        • The University of Kansas Hospital
        • Contact:
    • Massachusetts
      • Boston, Massachusetts, United States, 02118
        • Recruiting
        • Boston University School Of Medicine
        • Contact:
          • Marie-Helene Saint-Hilaire, MD
          • Phone Number: 617-638-8456
          • Email: neuromsh@bu.edu
    • Michigan
      • East Lansing, Michigan, United States, 48824
        • Recruiting
        • Michigan State University
        • Contact:
      • Farmington Hills, Michigan, United States, 48334
        • Recruiting
        • QUEST Research Institute
        • Contact:
      • West Bloomfield, Michigan, United States, 48322
        • Recruiting
        • Henry Ford Hospital
        • Contact:
    • New Hampshire
      • Lebanon, New Hampshire, United States, 03756
        • Recruiting
        • Dartmouth Hitchcock Neurology
        • Contact:
    • New Jersey
      • Summit, New Jersey, United States, 07902
        • Terminated
        • Atlantic Health System Hospital Corp.-Overlook Hospital
    • New York
      • Commack, New York, United States, 11725
        • Recruiting
        • David L. Kreitzman, MD., PC
        • Contact:
      • New York, New York, United States, 10016
        • Not yet recruiting
        • Fresco Institutute for Parkinson's and Movement Disorders
        • Contact:
      • New York, New York, United States, 10021
        • Terminated
        • Weill Cornell Medical College of Cornell University
    • North Carolina
      • Asheville, North Carolina, United States, 28806
        • Not yet recruiting
        • Asheville Neurology Specialists
        • Contact:
    • Ohio
      • Cincinnati, Ohio, United States, 45267-0525
        • Not yet recruiting
        • University of Cincinnati
        • Contact:
      • Toledo, Ohio, United States, 43614
        • Not yet recruiting
        • University of Toledo
        • Contact:
          • Stephanie Wilson
    • Oklahoma
      • Tulsa, Oklahoma, United States, 74136
        • Recruiting
        • The Movement Disorder Clinic of Oklahoma
        • Contact:
    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Recruiting
        • Penn State Milton S. Hershey Medical Center
        • Contact:
    • South Carolina
      • Charleston, South Carolina, United States, 29403
        • Not yet recruiting
        • Medical University of South Carolina
        • Contact:
    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Recruiting
        • Vanderbilt University Medical Center Vanderbilt Clinical Neurosciences
    • Texas
      • Bedford, Texas, United States, 76021
        • Not yet recruiting
        • North Texas Movement Disorders Institute
        • Contact:
      • Houston, Texas, United States, 77030
        • Recruiting
        • Baylor College of Medicine Department of Neurology
        • Contact:
    • Virginia
      • Charlottesville, Virginia, United States, 22911
        • Terminated
        • Charlottesville Medical Research
      • Virginia Beach, Virginia, United States, 23456
        • Terminated
        • Sentara Neurology Specialists
    • Washington
      • Kirkland, Washington, United States, 98034

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

28 years to 98 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subjects who successfully completed the core study IN 11 004 and, in the opinion of the Investigator, would benefit from long-term treatment with AP-CD/LD
  2. Continue to carry the diagnosis of Parkinson's disease consistent with UK brain bank criteria
  3. Has a good response to Levodopa in the opinion of the investigator
  4. Subjects able and willing to give written (signed and dated) informed consent to participate in the study

Exclusion Criteria:

  1. Participation in another clinical trial other than IN 11 004 and receipt of an investigational medication other than that administered in the context of IN 11 004 within 28 days prior to the planned start of treatment
  2. Previous or planned neurosurgical or Duodopa treatment for Parkinson's Disease (e.g., procedures including ablation or deep brain stimulation)
  3. Non-selective monoamine oxidase (MAO) inhibitors within 28 days prior to Baseline Visit or planned administration during study participation
  4. If, in the opinion of the Investigator, subject should not participate in the study
  5. Women who are pregnant or nursing. Women of childbearing potential who are not willing to use a medically acceptable method of contraception.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AP CD/LD
Accordion Pill™ Carbidopa/Levodopa Capsule 50/400mg , b.i.d or t.i.d or Accordion Pill™ Carbidopa/Levodopa Capsule 50/500mg , b.i.d or t.i.d
Accordion Pill™ Carbidopa/Levodopa Capsule 50/400mg , b.i.d or t.i.d or Accordion Pill™ Carbidopa/Levodopa Capsule 50/500mg , b.i.d or t.i.d
Other Names:
  • AP CD/LD

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unified Parkinson's Disease Rating Scale (UPDRS)
Time Frame: base line ( week 1) to end of study ( week 53)
Change from Baseline to End of Study (Week 53) in Parts I-IV
base line ( week 1) to end of study ( week 53)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety (Adverse Events, Safety laboratory, Vital signs)
Time Frame: One Year
Adverse Events, Safety laboratory, Vital signs
One Year
Change in Parkinson's disease Questionnaire - 39 items (PDQ39).
Time Frame: Base line to end of study ( week 53)
Change from baseline to End of Study in Parkinson's disease Questionnaire - 39 items (PDQ39).
Base line to end of study ( week 53)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter LeWitt, MD, Henry Ford Hospital - West Bloomfield

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2016

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

November 23, 2015

First Submitted That Met QC Criteria

November 25, 2015

First Posted (Estimate)

November 26, 2015

Study Record Updates

Last Update Posted (Actual)

August 14, 2018

Last Update Submitted That Met QC Criteria

August 12, 2018

Last Verified

December 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Clinical Trials on Accordion Pill™ Carbidopa/Levodopa

3
Subscribe